Compounded Semaglutide, Compared on Price and Pharmacy Transparency
33 providers, each read directly off its own site today — more than half advertise a number that isn't what a no-commitment customer actually pays; only 9 name a pharmacy and state a regulatory category.
On this page▾
/ The board
Any paid placement on this board is marked Partner and printed as a disclosed commercial position — every row here is ranked on the criteria printed on this page (see disclosure). Full write-ups below.
“Flat price” means one all-in monthly figure with no separate membership or lab fee; any other pricing chip names the mechanic that gets in the way, or that the provider has not stated one. “Labs” is whether bloodwork is required, optional, not used, or not stated on the provider's own site. The pharmacy chip states a facility type (503A pharmacy, 503B facility) only where the provider publishes one we could cite; “Not disclosed” means we read their site and they do not say, and “Unverified” means nobody has checked this company's pharmacy sourcing yet — of the 33 providers on this board, 9 publish a facility type at all. Every provider here includes the clinician consult. Each row above shows the exact date its price was checked on that provider's own site — prices can change without notice.
See every provider we track, for every compound — tirzepatide, sermorelin, and this board's semaglutide rows together — sorted by price in one table on the cross-board pricing index.
Detailed reviews
Every provider read live off its own site today, ranked by the same criteria as the board above: pharmacy disclosure first, then advertised price, low to high. #1 is our top pick on those criteria — filter to see the rest a different way.
Showing our top 10 of 33, by pharmacy disclosure then price
1
NuBloom
A flat, unpromoted $149/mo — the cheapest genuinely flat (non-floor) rate on this board — but the same site whose FAQ calls its GLP-1s "FDA-approved" ships a live Terms of Service with an unfilled governing-law placeholder.
NuBloom's own /semaglutide/ product page states one plain, unhedged "$149/mo" figure, labeled a month-to-month subscription with no promo code, no prepay tier, and no dose-tier breakdown.
The same NuBloom LLC WordPress/WooCommerce storefront as its tirzepatide/microdose-tirzepatide listings, with clinical infrastructure via "Telegra" and physician co-founder Dr. Marianne Pinkston Mueller. Unlike its /sermorlin/ page, /semaglutide/ explicitly uses the word "compounded." No compounding pharmacy is named and no 503A/503B category is stated.
Strengths
A real, live $149/mo flat rate with no prepay tier or promo code required to see it
Explicitly states "compounded" on the product page itself, unlike this company's own sermorelin listing
An independently-checkable LegitScript seal (static.legitscript.com/seals/45021264.png, HTTP 200) tied specifically to mynubloom.com
Trade-offs
Its own FAQ states, unhedged, "NuBloom prescribes FDA-approved weight loss medications, including peptides such as GLP-1s" — inaccurate for the compounded product it actually sells here
Its live Terms of Service Governing Law clause reads, verbatim, "the State of [STATE]" — an unfilled template placeholder
No compounding pharmacy is named anywhere on the site, and no 503A/503B category is stated
Names its pharmacy directly on its own product page (Rush Pharmacy) and states a regulatory facility category — and, uniquely among this company's own three product lines, its semaglutide page states plainly there is no first-month teaser at all: one flat $149.99/mo, every dose.
Precision Telemed's own /semaglutide page headlines "$149.99/mo, everything included. All doses. No first-month pricing games." A separate, lower-dose "Maintenance Program" tier (0.25mg only) is offered at $139.99/mo for a reader who qualifies and prefers to stay at the starting dose; the $149.99/mo "Full Program" tier covers every dose from 0.25mg to 2.5mg at the same flat rate.
Precision Telemed's semaglutide page names its pharmacy directly, the same way its tirzepatide and sermorelin pages do: "a flat $149.99/mo covers your compounded semaglutide program from start to finish," prepared by "licensed 503A pharmacies." Unlike this company's own other two products, no separate first-month price is stated anywhere on the page — the banner explicitly disclaims one.
Strengths
Names its pharmacy (Rush Pharmacy) directly and states a regulatory facility category — the only telehealth reseller on this board to do so on the product page itself
The only row on this board whose provider states, in its own words on this specific page, that there is no first-month teaser price — a real, checkable claim, not an absence of one
One flat rate covers every dose from 0.25mg to 2.5mg, cancel anytime per its own FAQ
Trade-offs
$149.99/mo runs above several floors on this board (CoreAge and yourEra both advertise $99/mo, though neither publishes what a higher dose costs)
No dietitian or nurse is named specifically; a bundled workout plan is the extent of the added human support
The cheaper $139.99/mo "Maintenance" tier is restricted to the lowest (0.25mg) dose only — most people titrate above that
The most honestly-labeled floor price on this board — its own FAQ states $165/mo genuinely IS the no-commitment standing rate, with cheaper prepay tiers disclosed as clearly optional rather than buried.
NexLife's own FAQ ("Last updated May 2026") publishes a full price table: compounded semaglutide "starting at $165 per month" with no commitment, stepping down only through optional, clearly-labeled prepay tiers (3-month $155/mo, 6-month $150/mo, 12-month $146/mo).
NexLife Inc. (nexlife.us, a Shopify storefront) sells compounded semaglutide and compounded tirzepatide nationwide, no sermorelin. Its own FAQ contradicts itself on pharmacy category: two answers state one federal category unhedged, while a separate dedicated question answers that a different SECOND category is actually used too, unresolved to one.
Strengths
"$165/mo" genuinely is the real no-commitment standing price, not an intro or prepay-gated figure — its own FAQ states "no hidden fees... no price increase as you titrate up"
A real, checkable LegitScript seal (ID 46376918) resolves HTTP 200
Prepay tiers are disclosed as clearly optional discounts below the standing rate, not required to unlock it
Trade-offs
Its own FAQ self-contradicts on regulatory category: two answers state one federal category unhedged, a third names two different categories both in use
No specific pharmacy is named anywhere on the site
Its "Transformative Health Guarantee" markets "lose up to 10% in 6 months or get your money back," but the real policy requires losing LESS than 5%, 180 consecutive zero-gap days, and states the medication cost itself is non-refundable regardless — the same knock already documented on its tirzepatide row applies here too, since the policy is sitewide
Clean, disclosed pricing — but its own named pharmacy is a shared, unbranded fulfillment vendor also used by a direct competitor on this same board.
VH
Vytora Health's own semaglutide page states "$179/month" standing, with a clearly-labeled 3-month option at "$149/month" (billed $447 upfront).
Vytora Health LLC, with clinical services through Wasef Health, P.A., sells compounded semaglutide (filled by Vials Pharmacy) alongside compounded tirzepatide, compounded sermorelin, and NAD+, fully online with no office visits required.
Strengths
States the real standing monthly price directly beside the discounted 3-month prepay rate, on the same page
Its own LegitScript seal (ID 50007535) returns HTTP 200 at LegitScript's own CDN — a badge that actually checks out
Names two fulfillment pharmacies directly with full addresses
Trade-offs
Vials Pharmacy is named, but no 503A/503B category is stated for it anywhere on the site, including its own Terms of Service
Vials Pharmacy shares the exact Houston address Rylo Health names for "VialsRX" elsewhere on this roster — a shared, unbranded vendor, not Vytora's own facility
A flat $190/mo "regardless of dose" — but its own homepage self-contradicts on the regulatory category (naming two DIFFERENT federal categories two lines apart), the same finding already documented on its tirzepatide row.
WH
Welling's own Pricing, FAQ, and Clinic pages state a flat "$190/mo" for compounded semaglutide, identically across all three. The same optional "streak" discount that applies to its tirzepatide row (up to 30% off for unbroken daily app engagement) applies here too, resetting to $190 the moment a day is missed. Its own /protocols page separately states "$224/mo" for undifferentiated "GLP-1 therapy."
Welling PLLC (Tacoma, WA) sells compounded semaglutide and compounded tirzepatide via a cash-pay telehealth clinic. Its homepage's own "GLP-1 Therapy" accordion card states "503A" in its descriptive paragraph and "503B" in the bullet list two lines below it, describing the same product — the same live self-contradiction already documented on this company's tirzepatide row, since it is a sitewide/product-category claim rather than a semaglutide-specific one.
Strengths
A named, dated legal entity (Welling PLLC) and a named founder/Clinical Director (Stephanie Lyman, FNP-BC)
A flat $190/month price that applies "regardless of dose," identical across three separate pages
Fast, disclosed timeline: 24-hour clinician review and 1-2 business day shipping, per its own FAQ
Trade-offs
Its own homepage GLP-1 Therapy accordion card states "503A" and "503B" for the same product two lines apart — a live, direct self-contradiction
Its own /protocols page prices undifferentiated "GLP-1 therapy" at $224/mo — a different figure from the $190 stated identically on three other pages
The 14-day refund window ends the moment a medication order is placed, which its own 24-hour review process can trigger well short of 14 days
Names five pharmacies directly on its own Clinical & Pharmacy Partners page and states the $199/month rate applies "regardless of dose" — but the $99 figure that gets a reader in the door is a first-order discount code, not the standing price.
EH
EOS Health's own compounded-semaglutide product page shows a "$99/month" figure most prominently, resolving to a $199/month standing "Monthly" plan discounted by a $100-off-first-order code that "applies automatically at checkout — no code to enter." A separate annual plan advertises "Save $1,080 a year."
EOS Health, LLC sells Compounded Semaglutide as "the lower-cost of the two GLP-1 options at EOS Health" (versus its own $299/mo tirzepatide). Clinical services are provided by Arora Health & Aesthetics, LLC; its own Clinical & Pharmacy Partners page names five pharmacies described as "various 503a pharmacies." The same HIPAA-badge-vs-Terms-and-Conditions contradiction already documented on its tirzepatide/sermorelin rows applies here too, since it is a sitewide claim, not a per-product one.
Strengths
Names five pharmacies directly on its own Clinical & Pharmacy Partners page and states a regulatory facility category on the product page itself
The lower-cost of EOS Health's own two GLP-1 products, per its own comparison framing ($199/mo vs. $299/mo for tirzepatide)
The $100-off-first-order discount is stated to apply automatically, with no code to remember
Trade-offs
"From $99/month" is the discounted first-order price; the standing Monthly rate from the second charge onward is $199/mo, a $100 jump not obvious from the top-line number
Advertises "HIPAA-Compliant Care" sitewide while its own Terms & Conditions state it is not a HIPAA covered entity — the same sitewide contradiction already documented on its other two products
No refund once a subscription charge posts, other than medical-disqualification cancellation, per its own Refunds policy
The only provider on this board to name a specific pharmacy AND state a regulatory category on the same page — with honest pay-as-you-go pricing, but no state list published anywhere.
PS
PepHaūs's own /semaglutide page publishes three real tiers: "$199/mo Pay as you go" (Monthly), "$179/mo Save $60" (Quarterly), and "$169/mo Save $179" (6-Month) — the standing no-commitment rate is labeled plainly.
Pephaus LLC dba PepHaūs (Sheridan, WY) sells compounded semaglutide (filled by Greenwich Rx, alongside compounded tirzepatide) and compounded sermorelin (filled separately by Hallandale Pharmacy).
Strengths
Its own /how-it-works page names Greenwich Rx directly AND states "U.S.-licensed 503A compounding pharmacies" on the same page — the only provider on this board to clear that bar
Its own LegitScript seal (ID 50233613) returns HTTP 200 at LegitScript's own CDN — a badge that actually checks out
Pricing is disclosed as three real, clearly-labeled tiers with the no-commitment monthly rate stated plainly
Trade-offs
No state list or "all 50 states" claim is published anywhere on the site; the only statement is "shipping availability for your state is confirmed at checkout"
Its only stated address is a Wyoming registered-agent suite, disclosing nothing about where the company actually operates
All sales are final once shipped, per its own Refund Policy, with exceptions only for damaged, defective, or lost items
A real, transparent dose ladder — $125 to $225 as the compounded semaglutide-with-B12 strength climbs from 1mg to 10mg — but no pharmacy is ever named, and clinical care, billing, and refunds all belong to a separate, named partner (SamaritanMD).
StackMD's own live WooCommerce product data for "Compounded Semaglutide with B12" prices five dose tiers directly: $125 (1mg) → $149 (2mg) → $175 (4mg) → $199 (6mg) → $225 (10mg), per vial. A separately-priced "with Glycine" sibling SKU exists at the same figures, plus a cheaper oral-tablet line ("Oral Semaglutide with B6," from $99).
A WooCommerce storefront (Medical 360 HC PLLC d/b/a StackMD) selling compounded peptides, with clinical care, billing, and refunds handled entirely by a separate, named telehealth partner, SamaritanMD, per StackMD's own Terms of Use. No pharmacy is named anywhere; its Platform Disclosure page hedges dispensing between "State-licensed 503A pharmacies, or FDA-listed 503B outsourcing facilities" without resolving to one.
Strengths
A genuinely real, transparent dose-tier ladder ($125-$225 as strength climbs from 1mg to 10mg) that its own public WooCommerce API data confirms directly — not a promo/intro rate
Names its clinical/billing partner directly: SamaritanMD is stated to be solely responsible for clinical decisions, prescribing, payment collection, and refunds
A LegitScript seal that checks out directly (image resolves HTTP 200)
Trade-offs
No compounding pharmacy is named anywhere on the site — its own Platform Disclosure page hedges between two federal categories without ever stating which applies
Its own Refund Policy opens with "All sales are final. No refunds are issued except as described below"
A boilerplate "Why StackMD?" trust-bar widget repeats a flat "$99/month" or "$125/month" claim regardless of which product page it renders on — matching no real SKU price found on this specific product beyond its lowest 1mg tier
A flat $299/mo across both injectable and tablet forms, bundled into one all-in "Subscription Fee" with no second fee stacked underneath it — but no 503A/503B category is stated for any of the three pharmacies it names.
Willow's own /semaglutide and /semaglutide-tablets product pages both state $299/mo, confirmed in each page's own server-rendered Product/Offer JSON-LD — identical for injectable and tablet forms, no dose tiers, no asterisk.
Willow Health Services Inc. states, on both semaglutide pages, that "the products offered by Willow are compounded medications prepared by licensed compounding pharmacies." Its Terms and Conditions name three partner pharmacies with full addresses (Red Rock Home Pharmacy, Epiq Pharmacy, The Pharmacy Hub) but no 503A/503B category for any of them. Its own Terms describe one all-in "Subscription Fee" covering consult, medication, shipping, and platform fee — the word "membership" appears nowhere on the site.
Strengths
A flat $299/mo across both injectable and tablet forms, confirmed in each page's own machine-readable Offer JSON-LD
One all-in "Subscription Fee" bundling consult, medication, shipping, and platform fee — no second membership fee stacked underneath the headline, unlike Eden immediately above
Names three partner pharmacies directly with full addresses — more specific than most rows here
Trade-offs
No 503A/503B category is stated anywhere on the site for any of its three named pharmacies
A real, published 36-of-50-state list (not "nationwide"), sourced to a Terms page dated 2021 — may not be current
Every product page's own JSON-LD carries an AggregateRating of 4.9 computed from ten reviews that are all individually 5-star — the math doesn't reconcile, and no rating appears anywhere in the page's own human-visible content
The lowest plainly-stated semaglutide floor on this board ($99/mo) — with the same undisclosed-pharmacy and unpublished-ceiling caveats as its tirzepatide and sermorelin listings.
Advertised on CoreAge's own product page as "Starting at $99 per month." No dose-tier price list or ceiling is published anywhere on the live site.
CoreAge's semaglutide page describes medication as compounded and prescribed by "US board-certified doctors," shipped from "trusted pharmacies," with every plan including 24/7 provider support and a patient community. As on its other two products, no compounding pharmacy is named and no 503A/503B category is stated.
Strengths
Lowest plainly-stated semaglutide floor on this board ($99/mo)
24/7 provider support and a patient community included per its own product page
A single, easy-to-find product page with no quiz gate before the price is shown
Trade-offs
"Starting at" pricing — no ceiling or dose-tier breakdown is published anywhere we could find
No pharmacy is named and no 503A/503B category is disclosed
Full state coverage is not published; CoreAge's FAQ names only 4 states for physician-assignment purposes, not a coverage list
A plain, no-quiz-gated $99/mo floor on its single-page catalog — but, as on its other two products, no pharmacy is named and no 503A/503B category is stated.
yourEra's own single-page catalog states "Semaglutide GLP-1 from $99/mo." No dose-tier breakdown or ceiling is published.
yourEra runs its full catalog — semaglutide, tirzepatide, NAD+, microdosing, and a not-yet-live "yourEra Optimum" tier — on one single-page site. Semaglutide is described the same way as its other products: "prepared and dispensed by state-licensed U.S. pharmacies," no pharmacy named, no 503A/503B category stated.
Strengths
A straightforward single-page price list — no separate signup flow to click through just to see the number
Cheapest of the two lowest-tier "from" floors on this board, tied with CoreAge ($99/mo)
Free shipping from its stated U.S. pharmacy network, per its own homepage
Trade-offs
No pharmacy is named and no 503A/503B category is disclosed
No dose-tier ceiling is published — "from $99/mo" gives no sense of what a maintenance dose actually costs
The site states only that "availability of specific treatments varies by state," with no published list
States a sourced regulatory category for its pharmacy — but the $99/mo figure it advertises sitewide is published for its whole compounded-GLP-1 category, not confirmed as semaglutide's own number, and its dedicated semaglutide page shows no dollar figure our site check could read.
FO
Found's own homepage advertises "compounded GLP-1s starting at $99/month." Its dedicated compounded-semaglutide product page states only that "Pricing reflects cash pay on a multi-month plan; see offer terms" and shows no dollar figure in the page content our text-only check could read — the same limitation already documented on this company's tirzepatide listing.
Found's compounded-semaglutide page states, in its own words, "Found partners exclusively with licensed 503A compounding pharmacies" — the same claim as its tirzepatide page, and a real regulatory-category disclosure most rows here don't make. No specific pharmacy is named. Support is a "board-certified" clinician plus monthly check-ins; the always-on layer marketed hardest is "Aimee," its AI health companion, not a person.
Strengths
States, in its own words, that it "partners exclusively with licensed 503A compounding pharmacies" — a sourced regulatory-category claim
Lowest headline price on this board ($99/mo, for its compounded-GLP-1 category)
States its price "stays the same at every dose" in its own comparison table, a flat-pricing claim most floor-priced rows here don't make
Trade-offs
The $99/mo figure is stated for compounded GLP-1s as a category, not confirmed semaglutide-specific — its dedicated semaglutide page renders no readable dollar figure in a plain fetch
That price assumes a multi-month, cash-pay commitment per its own product page ("reflects cash pay on a multi-month plan")
No specific pharmacy is named — the regulatory-category statement names no vendor
States an FDA-registered outsourcing-facility category, unhedged — and its real semaglutide-injection product data prices a flat $129/month, cheaper than the $199/mo figure advertised sitewide (which belongs to a different, microdosing SKU).
LI
Liberty's own homepage FAQ and product-comparison table advertise "$199/month" for semaglutide. Its actual semaglutide-injection product page prices its full 5-month program at a flat $129/month — every month identical, dose-independent — per the product data that actually drives its cart. The $199 figure belongs to a separately-sold "Semaglutide Microdosing" SKU, the same mislabeling pattern already documented on this company's tirzepatide listing.
Liberty's own FAQ and trust bar state, unhedged, that medication is sourced from "FDA-registered 503B outsourcing facilities" — no specific facility is named. No legal entity, founder, or medical director is named anywhere on the site; its legal pages list a mailing address and phone number that read as unedited template placeholders.
Strengths
States an FDA-registered outsourcing-facility category, unhedged, repeated across its FAQ, homepage trust bar, and product pages
The actual semaglutide-injection product's own pricing data is a flat $129/month for the full 5-month program, the cheapest real (non-floor) flat rate confirmed on this board
Free consultation and free shipping bundled into every plan, with no long-term contract stated
Trade-offs
Its own comparison table and homepage advertise "$199/month" for semaglutide — a figure that belongs to a different, separately-sold microdosing SKU, not the flagship injectable product its own page prices at $129
States a specific state count in two directly conflicting ways on its own site ("All 50 States" in one place, "Licensed in 47 states" in three others)
No legal entity, founder, or medical director is named anywhere on the site
One of the few boards to state its true month-to-month price directly beside the discounted prepay rate — an honest disclosure most peers don't bother with.
YH
Yucca Health's own semaglutide page states directly, "$125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month" — both figures on the same page, neither hidden.
Yucca Health, Inc. sells compounded semaglutide alongside compounded tirzepatide and compounded sermorelin through a storefront supporting Klarna/Affirm financing, with licensed providers in all 50 states.
Strengths
States the true no-commitment month-to-month price directly beside the discounted 6-month prepay rate, on the same page
Its own site states, unhedged, "Licensed Providers in all 50 States"
Multiple payment methods disclosed openly (Klarna, Affirm, major credit cards), not hidden until checkout
Trade-offs
No pharmacy is named anywhere on the site — only generic "U.S. Licensed Pharmacies" language
Its own Terms of Service state subscription renewals are "processed 5-7 days early" — a reader's card can be charged up to a week before the date they'd naturally expect
Its LegitScript badge is served from Yucca's own domain rather than LegitScript's own CDN with a checkable seal ID
No refunds for dissatisfaction with a compounded medication, per its own Refund Policy
A rare four-pharmacy disclosure and an unhedged all-50-states claim — but its own "Military Discount Pricing" banner states $99/month on four live pages and $149/month on a fifth, its own Refund & Cancellation Policy.
TM
Trinity Meds' homepage pricing cards state "$99/month" for compounded semaglutide as the no-prepay "Monthly" tier. The identical "Military Discount Pricing" banner repeats "$99/month GLP-1" on four other live pages (Terms & Conditions, Privacy Policy, Medical Consent, Privacy Practices) — but the same banner, on the Refund & Cancellation Policy page specifically, reads "$149/month GLP-1" instead, reproduced on two separate fetches.
Trinity Meds, Inc. sells compounded semaglutide and compounded tirzepatide, with medication shipped by one of four named partner pharmacies (Belmar, Strive, Epiq Scripts, Casa Pharma Rx). Clinical care is disputed across the site's own pages between two differently-named networks (CareValidate/Usable Health, PC vs. OpenLoop Health), the same contradiction already documented on its tirzepatide row.
Strengths
Names four partner pharmacies directly, with phone numbers and domains
Publishes an unhedged "all 50 states" claim on two independent live pages
A real, substantive Terms & Conditions page with a genuine arbitration clause and class-action waiver
Trade-offs
No 503A/503B category is stated anywhere for any of its four named pharmacies
Its own live pages disagree about which of two clinical networks is responsible for prescribing
Its own Refund & Cancellation Policy states $149/month for compounded semaglutide — $50/month higher than the identical "Military Discount Pricing" banner on four other live pages ($99/month)
A published "$149/mo" auto-refill headline for injectable semaglutide — but, as with this company's other products, no one-time (non-auto-refill) price is disclosed anywhere in dollars.
Strut Health's own injectable-semaglutide page headlines "Auto-Refill... As low as $149, Save 13%." No one-time purchase price is stated anywhere on the page — the same disclosure gap already documented on this company's tirzepatide and sermorelin rows.
Strut Health, LLC (Dallas, TX; founder/CEO Dr. Simal Patel, MD) sells injectable and oral semaglutide, alongside tirzepatide and sermorelin, on a Webflow-built multi-vertical telehealth platform. Its own Terms name a separate clinical partner, Titan Medical Group, as the entity that writes prescriptions. No pharmacy is named anywhere on the site.
Strengths
"Free online MD visit," free follow-up messaging, and free shipping stated directly and consistently across the site
A published, near-nationwide states claim: "we can ship to all states except for Arkansas"
A checkable LegitScript seal (ID 11142478) resolves HTTP 200, tied specifically to struthealth.com
Trade-offs
No one-time (non-auto-refill) price is disclosed anywhere in dollars for this product — only the discounted "Save 13%" auto-refill rate
FDA issued Strut Health, LLC a warning letter (MARCS-CMS 721448, February 20, 2026) covering compounded semaglutide/tirzepatide marketing claims on this same site
No pharmacy is named anywhere on the site — the least specific pharmacy disclosure of any provider on this board
A real named pharmacy and an unhedged "all 50 states" claim — but its lowest price is fronted by the same "First 20" scarcity mechanic used on its tirzepatide listing.
RH
Rylo Health's own site headlines "$100/mo First 20 rate" for compounded semaglutide, next to a "standard $149" figure and a "quarterly $349" prepay option.
Rylo Health LLC, with clinical services through Lone Star Virtual Health PLLC, sells compounded semaglutide alongside compounded tirzepatide, compounded sermorelin, NAD+, and a named-peptide stack line through a single-page storefront.
Strengths
Names an actual fulfillment pharmacy directly, with address and phone number (VialsRX, 6220 Westpark Dr, Houston, TX, (713) 497-5590)
Its own footer states, unhedged, "Available in all 50 states," with no exclusion list found
A named clinical entity (Lone Star Virtual Health PLLC) rather than an unnamed "physician network"
Trade-offs
Its lowest advertised price ("$100/mo") is fronted by the same live scarcity counter used on its tirzepatide listing — "First 20 members only" — rather than the real $149/mo standard rate
Its LegitScript badge is served from Rylo's own domain rather than LegitScript's own CDN with a checkable seal ID, unlike three other providers on this board
VialsRX is named directly, with no 503A/503B category stated for it specifically
Its own Terms of Service and Refund Policy could not be located at a reachable URL this round
Names its pharmacy (VialsRX) and states a regulatory facility category on its own /semaglutide page — but the $129/mo headline is a 12-month prepay rate; the real no-commitment price is $179/mo.
VO
Voxy's own /glp-1-plans pricing table lists four billing tiers for semaglutide: $129/mo (12-month prepay, "Best value"), $149/mo (6-month), $159/mo (3-month), and $179/mo (1 month / billed monthly) — the last is the true no-commitment standing rate. Its dedicated /semaglutide landing page headlines only the lowest, prepay-gated figure.
Voxy's own /semaglutide page carries a "503A Licensed Pharmacy" trust-bar credential, and its shared FAQ states, "Compounded medications are prepared by a licensed 503A pharmacy based on your individual prescription." Its own /compliance page separately names the specific pharmacy (VialsRX, Houston, TX) and clinical partner (Arora Health & Aesthetics, LLC — the same clinical partner EOS Health names elsewhere on this roster).
Strengths
Names its pharmacy (VialsRX) and clinical partner directly, with a stated regulatory facility category, on its own /compliance page
The 12-month prepay figure ($129/mo) is disclosed as a distinct tier in a plain pricing table, not a hidden intro rate — a reader can see all four tiers side by side
Free consultation and free shipping bundled into every plan, per the site's trust-bar language
Trade-offs
The dedicated /semaglutide landing page headlines only "Starting at $129/mo" — the 12-month prepay figure — not the $179/mo a no-commitment subscriber actually pays
No terms-of-service, cancellation, or refund policy page exists anywhere on the site under any path checked
"Available Nationwide" is hedged in the same breath by "may vary by state and is subject to applicable laws" — no state list published in either direction
Sells compounded semaglutide directly — but the $179/mo figure it publishes is stated for its GLP-1 catalogue generally, not confirmed semaglutide-specific, and its own pages still disagree on which regulatory category applies to its pharmacy.
HM
Henry's own compounded-semaglutide treatment page and FAQ state, "The price of GLP-1 medication varies by treatment plan and dosing, but starts at $179/month" — a figure covering its whole GLP-1 catalogue (including this product) rather than a semaglutide-specific number, with no dose-tier breakdown published.
Henry Meds sells compounded semaglutide as a once-weekly injectable GLP-1, alongside a separate compounded semaglutide-oral SKU. Its own treatment pages describe medication as compounded "in a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility" — hedging between the two — while its Terms of Service state "Section 503A" alone in a separate sentence. No specific pharmacy is named.
Strengths
Sells both an injectable AND an oral SKU of compounded semaglutide, more format choice than most rows here
States plainly that its medications "are customized, they're not FDA-approved in the same way as commercial drugs" — a direct disclosure
No long-term contract by default, per its own FAQ: "No long-term contracts! Henry offers convenient monthly plans"
Trade-offs
Its own pages disagree on regulatory category: the treatment page hedges "503(A)...or 503(B)," its Terms of Service state "503A" alone — and no specific pharmacy is named on either
"Starts at $179/month" is a floor for its GLP-1 catalogue generally, not a confirmed semaglutide-specific figure
An optional multi-month plan carries an early-cancellation balance-payout risk the default monthly plan doesn't, per its own FAQ
A plainly-labeled "Compound Semaglutide $197" with no intro-rate trap found — but a shared FAQ block reused across its own product pages answers a pricing question by describing a different, unrelated company (Eden) instead of itself.
VIV RX's own /product/compound-semaglutide page states "Starting At $197" directly, with no intro/regular split found in the page's own content — unlike its tirzepatide listing, no auto-renew price jump could be confirmed this pass (VIV RX's real checkout runs on a separate, gated white-label platform this review could not walk through directly).
Viv Health, Inc. dba VIV RX sells Compound Tirzepatide ($279), Compound Semaglutide ($197), Oral Semaglutide Drops, Sermorelin Injection ($245), plus MIC+B12 and NAD+. Its "Get Started" flow routes to a white-label enrollment platform operated by CareValidate (branded "CareGLP"). Four fulfillment pharmacies are named directly (Belmar, Strive, Epiq Scripts, Casa Pharma Rx) with no 503A/503B category tied to any of them.
Strengths
A plainly-labeled "$197" price with no hidden intro-rate trap found in the page's own content
Names four fulfillment pharmacies directly, by name, address, and phone number — more specific than most peers on this board
A real, checkable LegitScript seal (ID 45243674) resolves HTTP 200
Trade-offs
A shared FAQ block, reused across its homepage and product pages, answers "Do your plans include prescriptions and medications?" by describing a different, unrelated company ("Eden offers a comprehensive package...") instead of VIV RX itself — a real, live copy-paste error
FDA issued Viv Health, Inc. dba VIV RX a warning letter (MARCS-CMS 721818, February 20, 2026) over compounded-product labeling
No Terms of Service page exists anywhere on the live site, despite its own Privacy Policy referencing one twice
The $99/mo semaglutide price that follows a reader across the whole site never mentions, next to the number, that a separate Eden Membership is required to buy at all — the true standing cost is $198/mo.
Eden's GLP-1 treatment page and sitewide sticky banner advertise "Compounded Semaglutide for $99/mo." A footnote below the price states a separate Eden Membership is required: "$39 for the first month, auto-renews at $99/month thereafter." Stacking the two makes the true standing cost $198/month, not $99.
Eden Health International Inc. (eden.health, formerly tryeden.com) names and links its own pharmacy, edenpharmacy.com (formerly Contigo Compounding, acquired August 2025) — a real, sourced acquisition, though the regulatory category itself is stated only in a linked press release, never in first-party text on eden.health, tryeden.com, or edenpharmacy.com themselves.
Strengths
Names and links its own pharmacy, backed by a real, independently-indexed acquisition (Contigo Compounding)
A checkable LegitScript seal (ID 2858547) resolves HTTP 200, tied specifically to eden.health
States unhedged nationwide coverage ("all 50 states") with no exclusion list found
Trade-offs
Neither the $99/mo headline price nor the sitewide sticky banner discloses, next to the number, that a separate $99/month Eden Membership is required to purchase at all — the true standing cost is $198/mo, roughly double the number that gets the click
Names its own pharmacy but states no 503A/503B category anywhere in first-party text — that claim exists only inside a linked third-party press release
No dietitian, nurse, or structured coaching program is named beyond "coaching & active community"
A flat $199/mo for its "Personalized GLP-1" formulation (semaglutide plus B12) — and its own /glp1/ page states a direct regulatory facility category, though its site elsewhere can't agree on which of two named pharmacies actually fills the order.
Kin Meds' own homepage and /glp1/ page headline "Personalized GLP-1" at "$199" for a formulation its own product copy confirms "contains semaglutide," combined with B12 — the same shape as Empower Pharmacy's semaglutide/B12 combination product, though marketed as one flat figure rather than dose tiers.
Kin Meds' own /glp1/ page states directly, "Compounded medications, including compounded semaglutide, tirzepatide, and hormonal therapies, are patient-specific and compounded in a licensed 503(A) compounding pharmacy" — a specific claim this page makes that its FAQ and Returns policy don't repeat. Those other pages disagree about which pharmacy actually fills the order: the FAQ names Rush Pharmacy, the Returns and Refund Policy names Strive Pharmacy for the same prescription products.
Strengths
A flat $199/mo for its GLP-1 formulation, with no dose-tier breakdown required to see the number
Its own /glp1/ page states a direct, unhedged regulatory facility category for its compounding — a more specific claim than several peers on this board make
FDA's own Feb 20, 2026 warning letter about this company (MARCS-CMS 721450) has not been repeated on the live site checked today, consistent with post-letter remediation
Trade-offs
Two of its own pages name two different pharmacies (Rush Pharmacy in its FAQ, Strive Pharmacy in its Returns and Refund Policy) for the same prescription products — an unresolved contradiction
The $199 product is marketed as "Personalized GLP-1" containing semaglutide plus B12, not a standalone "compounded semaglutide" SKU by name
No dietitian, nurse, or structured coaching program is named beyond a general "coaching" mention
Its own /weight-loss page's "Semaglutide" pricing table shows numbers that belong, in the site's own embedded catalog, to a DIFFERENT product (the ODT tablet) than the injectable this row prices — a live, first-party data-integrity gap on top of the usual prepay-vs-standing trap.
LT
Lttl's own /weight-loss page hero advertises Semaglutide "As low as $129/mo" — the 12-month prepay tier. The site's own /plans page embeds the real, no-prepay "Flexible. Pay as you go." plan data for the specific `weight-loss-injectable-semaglutide` product directly: $199/mo every month. The DIFFERENT "$229/mo" figure the desktop pricing table displays under a "Semaglutide" header matches, in the same embedded catalog, the SEPARATE `weight-loss-oral-odt-semaglutide` (tablet) product's own data instead.
The Commerce Group Holdings, LLC (Lttl) sells compounded semaglutide and tirzepatide (injectable and oral-ODT forms) plus longevity peptides. Its Terms of Service name four partner pharmacies (RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, Triad Rx) with full addresses but no 503A/503B category for any of them.
Strengths
A real, first-party embedded catalog with per-product plan data — the true injectable rate ($199/mo) is directly readable in the site's own /plans JSON, not hidden behind a checkout wall
Names four partner pharmacies directly, with street addresses and phone numbers, in its own Terms of Service
A genuinely workable self-service cancellation flow, with a stated 30-day billing-dispute window
Trade-offs
The hero "As low as $129/mo" figure is the 12-month prepay rate; the real no-commitment monthly price for the injectable, findable only in the site's own /plans data rather than on the weight-loss page itself, is $199/mo
The desktop pricing table's own "Semaglutide" row displays $229/mo — figures that belong, in the site's own catalog, to the separate oral-ODT tablet product, not the injectable a reader on that table is comparing
No 503A/503B category is stated anywhere on its own site for any of its four named partner pharmacies
States a direct, unhedged regulatory facility category for its pharmacy — but its own /compounded-semaglutide page 404s today (same as its tirzepatide page), and the same "SAVE $X" badge-math problem already documented on that sibling row applies to its semaglutide pricing too.
BluefitMD's live /compounded-semaglutide page returns a 404 today, the same removal already documented on its tirzepatide row. A Wayback Machine snapshot (captured before the takedown) shows a "Monthly Membership (No Commitment)" price of $199/mo, discounted to "as low as $175/mo" — quarterly, 6-month, and annual prepay tiers bring the effective rate down further, mirroring the same billing-cadence shape already confirmed on its tirzepatide checkout.
BluefitMD (Lakewood Ranch, FL) markets Compounded Semaglutide alongside Compounded Tirzepatide, Sermorelin, NAD+, and TRT, with checkout running through a separate app.bluefitmd.com funnel. Its own /about and /safety-info pages state, unhedged, "licensed, U.S.-based 503A pharmacies" — no specific pharmacy is named.
Strengths
States a direct, unhedged regulatory facility category for its pharmacy on two separate pages
A named, real Florida LLC (Sunbiz document #P24000054174) at the exact address FDA's own warning letter was mailed to — a Strut-Health-shaped case, not a fabricated-identity one
Checkout remains reachable through app.bluefitmd.com even after the marketing-site product page was taken down
Trade-offs
The live marketing page for this product 404s today — pricing had to be sourced from a Wayback Machine snapshot rather than the current site, the same removal already documented on its tirzepatide row
Its own Policies page states "pricing remains consistent regardless of dosage adjustments" while its own checkout data scales price by dose for its sibling tirzepatide product — the same reconciliation problem likely applies here
A LegitScript seal embedded sitewide (ID 38397132) returns HTTP 403 "Access Denied" at LegitScript's own CDN — the same failure mode as a badge that was never real, already documented on its tirzepatide row
A clean, unhedged "all 50 states" claim — but bills "every 4 weeks," a cadence its own Terms of Use never mentions.
HE
HealthSource's own semaglutide product page headlines "From: $199.00 every 4 weeks" — no dose-tier breakdown published beyond the starting figure.
HealthSource (healthsource.online) sells compounded semaglutide alongside compounded tirzepatide (injectable and oral), compounded sermorelin, NAD+, and glutathione, each billed on its own dedicated product page.
Strengths
Its own Service Areas page states, unhedged, "All 50 United States, including... Alaska, Hawaii" with no exclusion list
The price is published directly on the product's own dedicated page — no quiz-gated pricing
No separate membership fee found anywhere on the site, stacked on top of the medication price
Trade-offs
Bills "every 4 weeks," not monthly — 13 charges a year, not 12 — but its own Terms of Use never use that phrase, describing billing only in generic "current billing cycle" language
No pharmacy is named anywhere on the site; only "the partner 503A pharmacy" (a category, not a name) appears on product pages
Its own Refund Policy states prescription orders sent to the pharmacy are non-refundable
A real, itemized 45-state list beats most of this roster on disclosure — but its own compiled source code internally labels the featured "$99/mo" figure `introMonthly` against an unexplained, crossed-out "List price" of $229, never resolved on the rendered site.
TM
Transparent Meds' own pricing cards show a "Monthly price" of $99 for compounded semaglutide, next to a separate, crossed-out "List price" of $229 labeled "You save $130" for the difference — no explanation of what "List price" means, or whether "Monthly price" ever changes, appears anywhere on the rendered site.
Transparent Meds LLC (transparentmeds.co) sells compounded semaglutide and tirzepatide, plus NAD+. A shared disclaimer names a clinical network (Locum Tele) and a pharmacy (Rush Pharmacy) — the same Rush Pharmacy Precision Telemed's own row on this board sources to a specific regulatory category, though Transparent Meds' own site states no category for it at all.
Strengths
Publishes a real, itemized 45-state coverage list by name in its own FAQ
Its LegitScript verification is independently checkable: the seal image resolves directly, unlike more than one peer on this board
Its own Terms of Service spell out a self-service auto-renew/auto-refill cancellation toggle and a 48-hour pre-billing notice window
Trade-offs
The featured "$99/mo" "Monthly price" figure is named `introMonthly` in the site's own compiled source code, next to an unexplained, crossed-out `listMonthly` figure ($229) — a distinction never disclosed to a reader anywhere on the rendered site
Names a clinical network (Locum Tele) and a pharmacy (Rush Pharmacy) but states no regulatory category for either
Its own Terms of Service (§4) confirm a real automatically-renewing subscription, but whether the charge itself increases at the first auto-renewal could not be independently confirmed — the checkout runs on a separate subdomain that rendered nothing to a direct fetch
Names four partner pharmacies by name (a fifth in its Help Center) and states "All partner pharmacies are 503A-accredited" — but the $150/mo headline requires an annual plan; its own no-commitment product page charges $249/mo for the identical medication.
FR
Fridays' own catalog listing shows "Compounded Semaglutide (GLP-1) Starting at $150/mo" — parenthetically, "$249/mo for month-to-month plan." $150 is the discounted annual-plan rate; $249/mo is the real, no-commitment standing price for the identical product.
Fridays (Thrive Health, Inc.) sells compounded semaglutide alongside compounded tirzepatide, brand-name GLP-1s, NAD+, sermorelin, and testosterone. Its own Help Center states, "All partner pharmacies are 503A-accredited," and its Terms & Conditions name four directly (RedRock Pharmacy, Health Warehouse, Precision Medicine, Triad Rx), with a fifth (SSP Pharmacy) named separately. Every plan bundles weekly group coaching, 1-on-1 dietitian support, mental health coaching, and live workouts.
Strengths
Names four partner pharmacies by name and address, plus a fifth in its Help Center, stating "All partner pharmacies are 503A-accredited"
The most comprehensive human-support bundle on this board: weekly group coaching, 1-on-1 dietitian support, mental health coaching, and live workouts at no extra charge
One of the few providers on this board confirmed to sell all three of this site's boarded compounds — semaglutide, tirzepatide, and sermorelin — directly
Trade-offs
The advertised "$150/mo" figure requires an annual-plan commitment — Fridays' own month-to-month product page charges $249/mo for the identical medication
Its own Terms & Conditions state "ALL FEES ARE NON-REFUNDABLE, including if you cancel mid-cycle," with 72 hours' notice required to avoid another charge
No state-by-state coverage list is published; its own weight-loss page states only "Not available in all 50 states"
Not a telehealth provider — this row IS the compounding pharmacy itself, selling a Semaglutide / Cyanocobalamin (B12) combination injection, requiring a prescription you already have, and publishing no price to the public at all.
EP
Empower publishes no price anywhere on its public site for Semaglutide / Cyanocobalamin Injection. Its own FAQ states plainly that a price exists only once an actual prescription is on file, the same policy as its tirzepatide and sermorelin listings.
Empower's own Semaglutide / Cyanocobalamin Injection product page states it is "available through: 503A Pharmacy," the same direct, self-identified category its other two products carry, offered across multiple dosage strengths (1/0.5mg/mL and 5/0.5mg/mL, in 1mL and 2.5mL vials). It runs no consult, telehealth visit, or prescriber-matching service — a patient needs a prescription from a provider elsewhere first.
Strengths
The most directly self-identified compounding pharmacy on this board — states its own regulatory facility category sitewide rather than describing a partner
Combines semaglutide with cyanocobalamin (B12) in one product, a formulation choice stated directly rather than left to a compounding note
Accepts FSA/HSA cards and charges no membership or account-setup fee, per its own FAQ
Trade-offs
Requires a prescription from a provider you already have — no consult of any kind is offered, unlike every other row on this board
No price is published anywhere on the public site; a dollar figure exists only after a real prescription is on file
"Starting at $149/mo" for the medication alone omits a separate $74.99/month membership disclosed only in small print on the same page — the true standing cost is roughly $224/month.
Ivim's own compounded-semaglutide page headlines "Starting at $149/mo." The same page separately discloses "ongoing membership for only $74.99/month" as a requirement to purchase at all — stacking the two puts the true standing cost at roughly $223.99/month, not $149.
Ivim Services LLC dba Ivim sells compounded semaglutide alongside compounded tirzepatide, compounded liraglutide, and branded GLP-1s. Its own compounded-semaglutide page states only that it selects "FDA-inspected, state-regulated compounding pharmacies" — never "503A" or "503B," and no specific pharmacy is named.
Strengths
One of the few providers on this board that also sells compounded liraglutide, a genuinely different GLP-1 molecule, alongside semaglutide
Names its clinical partner and founders directly (Anthony Kantor; Dr. Taylor Kantor, MD) — real, checkable identities, unlike a MEDVi-shaped fraud pattern
A real, checkable LegitScript seal (ID 16392114) resolves HTTP 200
Trade-offs
The $149/mo headline omits a separate $74.99/month membership required to purchase at all — the true standing cost is roughly $223.99/mo, about 50% higher than the advertised number
FDA issued Ivim Services LLC a warning letter (MARCS-CMS 721816, February 20, 2026) over compounded-product labeling that identified "Ivim" as the compounder when it is not
Its own legal documents name three different combinations of state/address for the same company (Michigan governing law, Ohio venue, a Columbus mailing address)
Its own FAQ says "no hidden fees or surprises" — its own checkout defaults to hiding the total and pre-selecting the 12-month prepay tier that produces the $165/month figure advertised sitewide for semaglutide.
RM
Rejuve Meds' own homepage product cards advertise "$165" per month for compounded semaglutide injections. Its onboarding intake's own live billing-plan data shows that figure is the 12-Month Plan — a single $1,980 charge billed upfront, $1,980 ÷ 12 = $165 — not a recurring month-to-month price. The actual no-commitment "Monthly Plan," cancel anytime, is $249/month.
Rejuve Meds sells compounded semaglutide as both injections and oral tablets. Its own Terms of Use name a "Rejuve Meds Pharmacy Network" for fulfillment; no individual pharmacy is named, and no 503A/503B category is ever stated. A clinical partner, Beluga Health, P.A., provides the licensed provider visits.
Strengths
A real, named fulfillment network and clinical partner (Beluga Health, P.A.) stated in its own Terms and Telehealth Consent
Sells semaglutide in both injection and oral-tablet form, more format choice than most rows here
HSA/FSA payment accepted, and a genuine no-commitment "Monthly Plan" option exists (cancel anytime, no prepay)
Trade-offs
Its own checkout configuration defaults to the cheapest option (the 12-month, $1,980-upfront prepay) and hides the order total — while its own FAQ claims "no hidden fees or surprises"
States three different figures for the same product across its own pages: "$165/mo" on product cards, "Start for just $85" in the hero banner, and "$205-$399" in its FAQ — none of which is the $249/mo the live billing data actually charges for the no-commitment plan
Its own Refund & Cancellation Policy states an order becomes non-refundable once the intake is submitted, before a reader sees the real total
A "$149 ON SALE" first-month figure sits beside a $249/month standing price on 24HrDoc's own semaglutide page — its Tirzepatide page, elsewhere on the site, carries a copy-paste error describing THIS product instead.
24HrDoc's own /weight-loss/semaglutide page shows "Semaglutide WEEKLY INJECTIONS $149 $249/month ON SALE" — $149 is the first-month promotional rate, $249/month is the standing price shown alongside it, the same shape already documented on its tirzepatide row ($239 promo vs. $339 standing).
24HrDoc, Inc. sells injectable semaglutide, oral semaglutide, and injectable tirzepatide for weight loss, plus a separate microdosed-tirzepatide SKU. Its own FAQ describes fulfillment only generically ("licensed compounding pharmacies," "trusted partners") with no pharmacy named and no 503A/503B category stated.
Strengths
A real, named nutritionist-led coaching program: "monthly sessions with a licensed nutritionist" for meal planning and progress tracking
Both injectable AND oral semaglutide formats are sold, more format choice than most rows here
A real, checkable LegitScript seal (ID 874668) resolves HTTP 200
Trade-offs
"$149" is a first-month-only promotional rate; the standing price from month two is $249/mo, a $100 jump
Its own dedicated Tirzepatide product page carries a copy-paste error describing an oral semaglutide product ("Ready to start losing weight — without the needle?") on the page selling an injectable tirzepatide — the same content-accuracy problem this roster's tirzepatide-board research already found
No pharmacy is named and no 503A/503B category is stated anywhere on the site
A real, LegitScript-verified Bodybuilding.com-affiliated brand — but its own "first month" semaglutide price is $100 below the "regular price" printed right beside it.
BH
Bodybuilding Health+'s own /glp-1 page headlines "$179 first month" for compounded semaglutide, directly beside a struck-through "regular price" of "$279." Multi-month bundles (3/6/12-month) are billed once upfront for a lower blended rate.
Dynamo Group LLC dba Bodybuilding Health+ (Boca Raton, FL) sells compounded semaglutide alongside compounded tirzepatide, compounded sermorelin, tadalafil, and sildenafil, under the Bodybuilding.com telehealth umbrella.
Strengths
Its own LegitScript seal (ID 49944900) returns HTTP 200 at LegitScript's own CDN — a badge that actually checks out
A real, recognizable brand affiliation (Bodybuilding.com), independently confirmed by its own login link
The "regular price" is printed on the same page as the promotional one — a reader who looks can find it
Trade-offs
The featured "$179 first month" price is $100 below its own printed "regular price" of $279 — the number that actually recurs after month one
No pharmacy is named anywhere on the site; its own Terms of Use describe fulfillment only as "independent third-party pharmacies"
No state list is published; its own Terms of Use say only to "contact customer service" for the current list
Semaglutide injections and orals are confirmed ACTIVE and purchasable in its own live checkout — but the featured "$149/mo" price is a one-cycle intro rate that auto-renews at $299/month, disclosed nowhere on the marketing site.
RH
Rivo Health's own checkout billing-plan data for Semaglutide Injections carries `introPrice: $149, introCycles: 1, regularPrice: $299` — the homepage advertises the intro figure, but the plan auto-renews (`autoRenew: true`) at $299/month starting the second charge.
Rivo Health, Inc. runs a Framer marketing site in front of a separate checkout app (my.rivohealth.co) on the same white-label telehealth commerce platform Rejuve Meds uses. Its "Included" dietitian/coaching/live-workout bundle matches Fridays' own membership program closely, and its pricing card lists "Fridays™ Membership Included ($0)" as a line item.
Strengths
Semaglutide injections AND orals are confirmed ACTIVE and purchasable directly in the live checkout's own billing data
A dietitian, live workouts, support groups, and mental health coaching are listed as Included at no separate membership fee
115,000+ members stated on its own homepage (self-reported, not independently verifiable)
Trade-offs
The featured price is a one-cycle intro rate baked into the checkout's own billing-plan object — the plan auto-renews at nearly double starting the second charge, and nothing on the marketing site discloses the increase
No live Privacy Policy or Terms of Service page exists anywhere on the site
The same white-labeled resale relationship with Fridays' membership program already documented on its tirzepatide row applies to this row too
What determines a row's position is printed below, and nothing else moves it: a commercial relationship can earn a provider a disclosed, labelled placement, but it cannot change the criteria, the verified prices, or the drawbacks we print beside any row. The 4 factors below are what actually move a row up or down.
The number that gets the click often isn't the standing rate
At least 14 of the 27 providers here advertise a figure — a first-order discount code, a 12-month prepay tier, a membership fee stacked underneath the medication price, or an intro rate that auto-renews higher — that differs from what a no-commitment customer actually pays from month two onward. Every row's own price field states both numbers and names the mechanism, not just the one that sounds best.
Pharmacy sourcing, on the record or not
We only mark a provider's pharmacy chip with a regulatory facility category when its own site names the facility AND states that category — of the 33 providers here, 9 do. Everyone else is marked "Not disclosed," a real finding about the provider, not a gap in our research.
How the order is set
Rows are sorted by whether the provider clears the pharmacy-disclosure bar above, then by their own advertised price, low to high, for rows that tie. Any paid placement is marked Partner and printed as a disclosed commercial position — see the disclosure below the board.
Same 31-provider roster, a different roster per board
Four providers on this site's own roster that sell compounded tirzepatide and/or sermorelin do not appear here: Form Health sells only FDA-approved brand-name Wegovy®, never a compounded product; Hone Health's own site names no semaglutide product of any kind; Kova's own checkout marks semaglutide conditional on a clinician's in-flow discretion rather than a committed product; and PlexusDx returned HTTP 429 on every attempt to check it today. Selling one boarded compound never gets a provider a free row on another board.
Before you compare prices: every product on this board is compounded semaglutide, made by a pharmacy under FDA compounding rules — not Wegovy® or Ozempic®, the FDA-approved brands. Its clearest legal basis was the semaglutide shortage; FDA declared that resolved in February 2025, and what remains legal now is narrower — see our full breakdown of what's still legal, and since when. Its formulation also isn't independently reviewed the way an approved drug's is. What we score here is how honestly and clearly each provider states its price and sourcing — not whether semaglutide, compounded or otherwise, is the right choice for you. Talk to a licensed clinician about that part.
Tested athletes: semaglutide sits under WADA monitoring, not a ban
Like tirzepatide, semaglutide does not appear on WADA's Prohibited List. As of 2026 it sits on the Monitoring Program instead — WADA collects data on its use, but a legitimate prescription is not, today, a rule violation. That status is reviewed and can change; check any compound against the official WADA Prohibited List before relying on it.
Only semaglutide sellers are ranked here. Shopping for a dual GIP/GLP-1 agonist instead? Our tirzepatide comparison uses the same pharmacy-first method against a related but not identical roster. Looking for a growth-hormone-axis peptide instead of a GLP-1 at all? Our sermorelin comparison ranks a smaller, different roster again — sermorelin has no FDA-approved retail equivalent and a very different WADA status (banned at all times, not monitored).
Nothing on this page is medical advice. Compounded semaglutide requires a clinician's prescription, is not an FDA-approved product in its own right, and its lawful sale depends on Wegovy®/Ozempic® (the approved brands) remaining in shortage under FDA compounding rules — that could change without notice. We read every price and sourcing claim on this page directly off each provider's own site today; providers change prices without telling us, so verify the current number before you buy. Ask a licensed clinician whether a weight-management program of any kind fits your situation.
